Product Information
LORAZEPAM 1 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0360 per EA under NDC 00093342601. Its NADAC has been published 240 times since Jan 19, 2022.
FDA first approved this application on Oct 31, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093342601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA072927FDA Approved
10/31/1991
TE Code
AB
On Market Since
12/9/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 1 MG TABLET has been published 240 times since Jan 19, 2022, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0360 per EA |
|---|---|
| All-time high | $0.0559 (Apr 10, 2024) |
| All-time low | $0.0341 (Nov 20, 2024) |
| 52-week high | $0.0493 |
| 52-week low | $0.0360 |
| Median price | $0.0432 |
| Average price | $0.0443 |
| Largest weekly change | -32.4% (Nov 20, 2024) |
| Weeks tracked | 240 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 1 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0360 per EA (NDC 00093342601), effective Aug 19, 2026.
How has the price of LORAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 1 MG TABLET has declined 20.6%. It has been tracked across 240 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 1 MG TABLET?
Since Jan 19, 2022, the NADAC for LORAZEPAM 1 MG TABLET has ranged from a low of $0.0341 (Nov 20, 2024) to a high of $0.0559 (Apr 10, 2024), with a median of $0.0432 per EA.
Are there cheaper alternatives to LORAZEPAM 1 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 1 MG TABLET, is $0.0239 per EA — about 34% below LORAZEPAM 1 MG TABLET.
Who manufactures LORAZEPAM 1 MG TABLET?
LORAZEPAM 1 MG TABLET (NDC 00093342601) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.